Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases
Therefore, a better understanding of the dysregulation of the antioxidant KEAP1-NRF2 activity in ALS could help to develop novel therapeutic strategies able to halt disease progression, prolonging patients survival
Melanotan II, by contrast, is a cyclic heptapeptide engineered to be more potent but less selective
While the clinical impact of GLP-1s on approved indications (e.g., obesity, diabetes, cardiovascular risk) and adjacent indications is being studied extensively in clinical trials, there is limited scientific literature on GLP-1 use, efficacy or persistence outside of clinical trial settings
in research it is frequently studied as its copper complex for its role in copper-binding and cellular-signaling pathways
So the longer you're in the sun, the weaker its protection gets